Scarica l'app Stockscreener
9.12
1.30%
-0.12
Dopo l'orario di chiusura:
9.12
Puma Biotechnology Inc Borsa (PBYI) Ultime notizie
Puma (PBYI) Latest Quarter: The Available Earnings Metric Delivers a Beat; Investor Response: The Stock Ends Down 4.00% for the Current SessionEarnings Turnaround - vinanet.vn
Puma Biotechnology (PBYI) Q2 2026 Earnings Call Transcript - AOL.com
Puma (PBYI) Latest Quarter: EPS Lands Above Forecast in the Current Update; Trading Move: Shares Move 4.76% Up in the Latest SessionEPS Growth Report - vinanet.vn
Puma Biotechnology (NASDAQ:PBYI) Upgraded at Wall Street Zen - MarketBeat
Puma Biotechnology Inc (PBYI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is Puma Biotechnology (PBYI) a Great Value Stock Right Now? - Yahoo Finance
Puma Biotechnology, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PBYI) 2026-08-10 - Seeking Alpha
Puma Biotechnology Reports $56.5M Revenue and Profitability in Q2 - sekbernews.id
Puma Biotechnology (PBYI) Stock Jumps On Profit Strength As Earnings Outlook Fades - Sahm
Puma Biotechnology (NASDAQ:PBYI) Issues Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat
Puma Biotech earnings beat by $0.16, revenue topped estimates - Investing.com Nigeria
TD Cowen Forecasts Strong Price Appreciation for Puma Biotechnology (NASDAQ:PBYI) Stock - marketbeat.com
Transcript : Puma Biotechnology, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised - Yahoo Finance
Puma Biotechnology, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Puma Biotechnology’s Douglas M. Hunt sells $69,904 in shares - Investing.com
Puma Biotechnology Q2 Earnings Call Highlights - MarketBeat
Puma Biotechnology Inc (PBYI) (Q2 2026) Earnings Call Highlights: Debt-Free Status and Raised ... - finance.yahoo.com
Puma Biotech (PBYI) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Earnings call transcript: Puma Biotechnology tops Q2 2026 estimates as profit returns - Investing.com
Puma Biotechnology Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Puma Biotech: Q2 Earnings Snapshot - aol.com
PUMA BIOTECHNOLOGY, INC. 2026: Revenue $56.5M, EPS $0.16— 10-Q Summary - TradingView
Puma Biotechnology Reports Second Quarter 2026 Financial Results - marketscreener.com
Puma Biotechnology, Inc. Provides Earnings Guidance for the Third Quarter of 2026 - marketscreener.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Finviz
Puma Biotechnology Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results - The National Law Review
Puma Biotechnology (PBYI) Gains 1.43% to $7.8, Holds Above Key Support at $7.41PCR Mean Reversion - dars.gov.et
Renaissance Technologies LLC Cuts Position in Puma Biotechnology, Inc. $PBYI - MarketBeat
Earnings Preview: Puma Biotech (PBYI) Q2 Earnings Expected to Decline - Yahoo Finance
Puma Biotechnology (PBYI) Slips 1.88% as Stock Tests Key Support LevelsSMA Signal - dars.gov.et
Puma Biotechnology Inc Revenue Breakdown – NASDAQ:PBYI - TradingView
Puma Biotechnology Inc (PBYI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Puma Biotechnology Inc (PBYI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Puma Biotechnology Inc (PBYI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ETFs Investing in Puma Biotechnology, Inc. Stocks - TradingView
PBYI|Puma Biotechnology Inc|Price:7.980|Chg%:-0.030 - TradingKey
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results - WBOC TV
Puma Stock Puma Biotechnology Inc Discount Puma Biotechnology Acquisition Outlet Online PUMA Biotechnology Form S - มูลนิธิเพื่อผู้บริโภค มพบ.
Puma Biotechnology’s Douglas M. Hunt sells $69,904 in shares By Investing.com - Investing.com Nigeria
Puma biotechnology CFO Maximo Nougues sells $77,556 in stock By Investing.com - Investing.com South Africa
Form 4 Puma Biotechnology Inc For: 8 July By Investing.com - Investing.com Nigeria
Alan Auerbach, Puma Biotechnology president and CEO, sells $364,051 By Investing.com - Investing.com South Africa
Puma Biotechnology (PBYI) CEO sells 44,058 shares under 10b5-1 plan - Stock Titan
Puma Biotechnology (PBYI) CFO sells 9,386 shares in 10b5-1 trade - Stock Titan
Alan Auerbach, Puma Biotechnology president and CEO, sells $364,051 - Investing.com
Form 144 PUMA BIOTECHNOLOGY For: 6 July By Investing.com - Investing.com Nigeria
[144] PUMA BIOTECHNOLOGY, INC. SEC Filing - Stock Titan
Puma Biotechnology (PBYI) Faces Resistance as Shares Pull Back Toward Key SupportMarket Neutral Pair - dars.gov.et
Price to sales forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView
PBYIPuma Biotechnology Inc Latest SEC Filings - Finviz
Puma Biotechnology highlights targeted cancer therapies as investors watch Nasdaq-listed PBYI - Ad-hoc-news.de
PBYI News | PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) - ChartMill
Puma Biotechnology awards stock to four new employees - Stock Titan
Puma Biotechnology, Inc.(NasdaqGS:PBYI) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 2500 Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 2000 Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 3000E Growth Benchmark - marketscreener.com
0.00%
3.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):